(Q28140955)

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

The complexities of T-cell co-stimulation: CD28 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

CTLA-4 can function as a negative regulator of T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

CTLA-4 ligation blocks CD28-dependent T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Co-stimulation in T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Models of T cell anergy: is there a common molecular mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

The B7 and CD28 receptor families

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Genomic organization of the mouse B-lymphocyte activation antigen B7

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Identification of an alternatively spliced form of the murine homologue of B7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Alternative splicing in the control of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

A naturally occurring soluble isoform of murine Fas generated by alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

New forms of dog CD80 and CD86 transcripts that encode secreted B7 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

T-cell co-stimulation through B7RP-1 and ICOS

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Structure and evolution of the extended B7 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5

Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC5